Skip to main content
. Author manuscript; available in PMC: 2021 May 12.
Published in final edited form as: Phys Med Biol. 2020 Apr 14;65(7):075006. doi: 10.1088/1361-6560/ab7632

Table 3.

Percent error from measured light dose at the end of treatment with calculated light fluence using the (a) primary component (equation (1)), only the (b) primary component with CF, the (c) primary and scattering component (equation (2)), and the (d) primary and scattering component with CF (equation (3)) The values in the parenthesis are the values for the detector position extrapolated from the method described in section 2.6 since the actual detector positions were not available.

(a) Primary component only
Case no. Diaph PS AS PM PCW ACW Peri Apex Avg.
008 (40.7%) (41.7%) (35.1%) (36.4%) (29.6%) (59.8%) (56.2%) (32.2%) 42% ± 11%
012 39.8% 56.4% 57.2% 58.5% 51.0% 56.6% 29.2% 45.8% 49% ± 10%
014 52.9% 46.9% 63.9% 42.4% 46.5% 67.6% 51.8% 50.0% 53% ± 9%
016 50.0% 47.4% 52.4% 58.3% 41.2% 56.5% (47.1%) (60.9%) 52% ± 7%
017 39.4% 49.3% 63.4% 44.5% 28.2% 39.6% 29.2% 45.7% 42% ± 11%
018 43.2% 52.8% 62.1% 52.1% 45.4% 63.0% 58.9% 61.4% 55% ± 8%
020 52.2% 63.6% 58.7% 59.0% 53.2% 58.0% 60.6% 67.5% 59% ± 5%
Avg. 46% ± 6% 51% ± 7% 56% ± 10% 50% ± 9% 42% ± 10% 57% ± 9% 48% ± 13% 52% ± 12%
(b) Primary and scattering component
Case no. Diaph PS AS PM PCW ACW Peri Apex Avg.
008 (10.6%) (6.4%) (7.6%) (5.1%) (10.4%) (9.3%) (6.1%) (12.9%) 9% ± 3%
012 13.8% 7.4% 10.1% 10.2% 5.4% 8.3% 15.8% 1.3% 9% ± 5%
014 1.0% 6.3% 3.0% 3.7% 9.0% 3.2% 1.2% 15.1% 5% ± 5%
016 2.5% 1.7% 5.9% 4.2% 15.4% 13.9% (14.6%) (9.4%) 9% ± 6%
017 12.9% 8.7% 6.7% 14.9% 6.6% 14.7% 13.7% 13.1% 11% ± 4%
018 13.6% 5.7% 9.0% 4.2% 9.2% 9.4% 6.5% 8.9% 8% ± 3%
020 3.1% 8.3% 3.5% 2.5% 1.6% 2.4% 6.1% 13.1% 5% ± 4%
Avg. 8% ± 6% 6% ± 2% 7% ± 3% 6% ± 5% 8% ± 4% 9% ± 5% 9% ± 6% 11% ± 5%
(c) Primary component with dual correction (CF)
Case no. Diaph PS AS PM PCW ACW Peri Apex Avg.
008 (20.4%) (10.4%) (14.0%) (12.1%) (14.8%) (13.9%) (14.1%) (8.1%) 14% ± 4%
012 20.5% 21.6% 10.1% 26.3% 16.7% 13.3% 0.8% 1.3% 14% ± 9%
014 1.0% 6.3% 35.0% 3.7% 9.0% 32.1% 1.2% 15.1% 13% ± 14%
016 2.5% 18.1% 22.5% 4.2% 15.4% 19.3% (7.9%) (10.7%) 13% ± 7%
017 15.2% 8.3% 23.5% 17.6% 6.6% 13.5% 19.7% 15.0% 15% ± 6%
018 13.6% 3.8% 9.0% 18.6% 7.2% 18.6% 5.6% 0.4% 10% ± 7%
020 24.3% 8.9% 6.4% 24.3% 47.1% 6.9% 17.3% 4.4% 18% ± 14%
Avg. 14% ± 9% 11% ± 6% 17% ± 10% 15% ± 9% 17% ± 14% 17% ± 8% 10% ± 8% 8% ± 6%
(d) Primary and scattering component with dual correction (CF)
Case no. Diaph PS AS PM PCW ACW Peri Apex Avg.
008 (6.6%) (2.1%) (2.2%) (4.5%) (8.6%) (6.9%) (5.4%) (9.9%) 6% ± 3%
012 8.6% 1.2% 4.3% 5.4% 5.1% 5.4% 10.2% 2.9% 5% ± 3%
014 4.5% 9.0% 7.5% 7.9% 3.5% 4.3% 5.5% 9.0% 6% ± 2%
016 1.9% 2.8% 5.3% 3.1% 9.8% 8.2% 6.8% 9.7% 6% ± 3%
017 8.9% 3.8% 1.7% 8.3% 4.3% 11.2% 9.8% 3.5% 7% ± 4%
018 4.0% 2.3% 8.1% 0.8% 3.4% 7.1% 11.2% 6.6% 5% ± 3%
020 6.2% 4.7% 1.0% 6.4% 12.4% 2.3% 1.6% 0.4% 5% ± 4%
Avg. 6% ± 3% 4% ± 3% 4% ± 3% 5% ± 3% 7% ± 4% 7% ± 3% 7% ± 3% 6% ± 4%